Blog
Pearl’s Diana Caldwell to serve on April IHIF lunch panel
IHIF is hosting a lunch panel on April 16th, featuring Pearl’s Diana Caldwell and other industry professionals to discuss the impact of the service sector on life sciences in Indiana. What: IHIF Lunch Series Topic: “Indiana’s Life Science Service Sector” When:...
Risk-Based Algorithm helps Clinical trial monitoring
A new report from PricewaterhouseCoopers (PwC) found that the use of a risk-based algorithm to monitor clinical studies reduced the deployment of research associates and targeted more high-risk patients and sites. Although CROs and sponsors have been hesitant to use...
inVentiv Health Clinical partners with Mytrus
inVentiv Health Clinical recently invested in Mytrus, a California based “Virtual Trial” company. Mytrus has previously parted with Pfizer to create REMOTE, an “at home” clinical study of the bladder control drug, Detrol LA. Although the Pfizer study failed to meet...
Tufts CSDD releases new report
In 2012, an all-time high of 28,000 principal investigators participated in FDA regulated research, according to a study in the March/April Tufts Center for the Study of Drug Development (CSDD) Impact Report. However, compound annual growth in the number of active...
Study reveals correlation between number of patients and phase of oncology clinical trials
A recent study, “Oncology Clinical Trials: Drug Development and Case Studies” examined the average number of patients per site during different phases of oncology trials. The study found that Phase 1 trials averaged 12.9 patients per site, while Phase 2 and Phase...